271 related articles for article (PubMed ID: 10082071)
1. Comparative tolerability and efficacy of treatments for impotence.
Meinhardt W; Kropman RF; Vermeij P
Drug Saf; 1999 Feb; 20(2):133-46. PubMed ID: 10082071
[TBL] [Abstract][Full Text] [Related]
2. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM
Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074
[TBL] [Abstract][Full Text] [Related]
3. A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?
Hatzimouratidis K; Hatzichristou DG
Drugs; 2005; 65(12):1621-50. PubMed ID: 16060698
[TBL] [Abstract][Full Text] [Related]
4. SOP conservative (medical and mechanical) treatment of erectile dysfunction.
Porst H; Burnett A; Brock G; Ghanem H; Giuliano F; Glina S; Hellstrom W; Martin-Morales A; Salonia A; Sharlip I;
J Sex Med; 2013 Jan; 10(1):130-71. PubMed ID: 23343170
[TBL] [Abstract][Full Text] [Related]
5. [Drugs for impotence].
Lukkarinen O; Pelkonen R
Duodecim; 1995; 111(8):771-6. PubMed ID: 8681837
[No Abstract] [Full Text] [Related]
6. [Erectile dysfunction].
Lyngdorf P
Ugeskr Laeger; 2002 Oct; 164(41):4779-83. PubMed ID: 12407881
[No Abstract] [Full Text] [Related]
7. [New treatment options for erectile dysfunction. Pharmacologic and nonpharmacologic options].
Sperling H; Lümmen G; Schneider T; Rübben H
Herz; 2003 Jun; 28(4):314-24. PubMed ID: 12825147
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
[TBL] [Abstract][Full Text] [Related]
9. Drugs for the treatment of impotence.
Garcia-Reboll L; Mulhall JP; Goldstein I
Drugs Aging; 1997 Aug; 11(2):140-51. PubMed ID: 9259177
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of sildenafil, phentolamine, yohimbine and L-arginine on the rabbit corpus cavernosum.
Sharabi FM; Daabees TT; El-Metwally MA; Senbel AM
Fundam Clin Pharmacol; 2004 Apr; 18(2):187-94. PubMed ID: 15066133
[TBL] [Abstract][Full Text] [Related]
11. [Endocavernous drug infusions revisited].
Bellorofonte C; Ruoppolo M; Dell'Acqua S; Zaatar C; Ferri PM; Yamak R; Tagliaferri A; Tombolini P
Arch Ital Urol Nefrol Androl; 1991 Dec; 63(4):475-9. PubMed ID: 1838835
[TBL] [Abstract][Full Text] [Related]
12. PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes.
Rosen RC; McKenna KE
Annu Rev Sex Res; 2002; 13():36-88. PubMed ID: 12836729
[TBL] [Abstract][Full Text] [Related]
13. Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil--a comparative study in 103 patients with erectile dysfunction.
Porst H
Int J Impot Res; 1997 Dec; 9(4):187-92. PubMed ID: 9442415
[TBL] [Abstract][Full Text] [Related]
14. New treatment options for erectile dysfunction in patients with diabetes mellitus.
Basu A; Ryder RE
Drugs; 2004; 64(23):2667-88. PubMed ID: 15537369
[TBL] [Abstract][Full Text] [Related]
15. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
[TBL] [Abstract][Full Text] [Related]
16. Self-administration in the pharmacological treatment of impotence.
Bénard F; Lue TF
Drugs; 1990 Mar; 39(3):394-8. PubMed ID: 2184008
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological therapy in erectile dysfunction--current standards and new viewpoint].
Schultheiss D; Stief CG; Truss MC; Jonas U
Wien Med Wochenschr; 1997; 147(4-5):102-4. PubMed ID: 9190765
[TBL] [Abstract][Full Text] [Related]
18. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
Asuar Aydillo S
Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
[No Abstract] [Full Text] [Related]
19. Pharmacological aspects of erectile dysfunction.
Thomas JA
Jpn J Pharmacol; 2002 Jun; 89(2):101-12. PubMed ID: 12120751
[TBL] [Abstract][Full Text] [Related]
20. Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil--a comparative study in 103 patients with erectile dysfunction.
Lewis RW
Int J Impot Res; 1998 Mar; 10(1):61-2. PubMed ID: 9542692
[No Abstract] [Full Text] [Related]
[Next] [New Search]
